Related Experiment Video
Updated: Jun 8, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Pain management in children and adolescents with sickle cell disease
Jeanette M Jerrell1, Avnish Tripathi, James R Stallworth
1Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, South Carolina 29203, USA. Jeanette.Jerrell@uscmed.sc.edu
Insights
Combining stronger opioids with antidepressants or anticonvulsants may reduce sickle cell disease (SCD) pain visits. This study explored medication effectiveness for vaso-occlusive (VOC) pain episodes in children with SCD.
Area of Science:
- Pediatric Hematology
- Pain Management
- Pharmacology
Background:
- This study analyzed medication use for vaso-occlusive (VOC) pain in 2,194 children with sickle cell disease (SCD).
- Common treatments included NSAIDs and weak opioids, with stronger opioids and adjunctive medications prescribed for frequent pain episodes.
Discussion:
- Stronger opioids combined with SSRI antidepressants or anticonvulsants showed a significant association with fewer acute VOC pain visits.
- This suggests potential benefits of multimodal pain management strategies in SCD.
Key Insights:
- Medication patterns for VOC pain vary, with more intensive treatments for severe cases.
- Combined use of stronger opioids and adjunctive antidepressants/anticonvulsants correlates with reduced pain recurrence.
Outlook:
- Further research into optimizing combination therapies for chronic pain management in pediatric SCD is warranted.
- Findings support exploring adjunctive antidepressants or anticonvulsants alongside primary pain relievers for long-term VOC pain relief.
Abstract:
In a cohort of 2,194 children with sickle cell disease (SCD) treated in community-based services, we explored the types of medications used to treat vaso-occlusive (VOC) pain episodes, and the relative effectiveness of nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, and adjunctive antidepressants or anticonvulsant medications on reducing acute VOC pain visits over time. Pharmacologic treatments for VOC pain consisted mainly of NSAIDs and weak opioids. Significantly more patients with more than 3 inpatient or ER VOC pain visits during their first year of SCD treatment were prescribed stronger opioids, SSRIs, SNRI/heterocyclics, and anticonvulsants. Prescription of both stronger opioids and SSRI antidepressants or anticonvulsants was significantly associated with lower cumulative rates of acute VOC pain visits over time. Using an observational study design and existing clinical data, these findings are intended to illustrate the potential clinical advantages of combining adjunctive antidepressants or anticonvulsants with primary pain medications for relief of acute VOC pain over time.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Pharmacokinetics in Pediatric Patients: Drug Excretion
Peripheral Artery Disease IV: Nursing Management
Analgesia and Pain Management
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Tonsillitis II: Management